Parkinsonian Disorders

"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Descriptor ID	D020734
MeSH Number(s)	C10.228.140.079.862 C10.228.662.600
Concept/Terms	Parkinsonian Disorders Parkinsonian Disorders Parkinsonian Syndrome Parkinsonism Parkinsonian Syndromes Parkinsonian Diseases Autosomal Dominant Parkinsonism Autosomal Dominant Parkinsonism Dominant Parkinsonism, Autosomal Parkinsonism, Autosomal Dominant Autosomal Recessive Juvenile Parkinson Disease Autosomal Recessive Juvenile Parkinson Disease Chromosome 6-Linked Autosomal Recessive Parkinsonism Chromosome 6 Linked Autosomal Recessive Parkinsonism Familial Parkinson Disease, Autosomal Recessive Juvenile Parkinson Disease, Autosomal Recessive Juvenile Parkinsonism, Autosomal Recessive Parkinsonism, Early Onset, with Diurnal Fluctuation Parkinsonism, Juvenile, Autosomal Recessive Parkinson Disease 2, Autosomal Recessive Juvenile Parkinsonism, Early-Onset, With Diurnal Fluctuation Parkinson Disease, Juvenile, Autosomal Recessive Parkinson Disease 2 Parkinson Disease Autosomal Recessive, Early Onset Autosomal Recesssive Juvenile Parkinsonism Parkinson Disease, Familial, Autosomal Recessive Ramsay Hunt Paralysis Syndrome Ramsay Hunt Paralysis Syndrome Familial Juvenile Parkinsonism Familial Juvenile Parkinsonism Juvenile Parkinsonism, Familial Parkinsonism, Familial Juvenile Parkinsonism, Experimental Parkinsonism, Experimental Experimental Parkinsonisms Parkinsonisms, Experimental Parkinson Disease, Experimental Experimental Parkinsonism, MPTP-Induced Experimental Parkinsonism, MPTP Induced Parkinsonism, MPTP-Induced Experimental MPTP-Induced Experimental Parkinsonism MPTP Induced Experimental Parkinsonism Experimental Parkinson Disease Diseases, Experimental Parkinson Experimental Parkinson Diseases Parkinson Diseases, Experimental Experimental Parkinsonism Parkinsonism, Juvenile Parkinsonism, Juvenile Juvenile Parkinsonism Juvenile Parkinsonisms Parkinsonisms, Juvenile Parkinson Disease, Juvenile Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Autosomal Dominant Juvenile Parkinson Disease Juvenile Parkinson Disease, Autosomal Dominant Parkinsonism, Juvenile, Autosomal Dominant Parkinson Disease, Autosomal Dominant. Juvenile Parkinson Disease, Juvenile, Autosomal Dominant Autosomal Dominant Juvenile Parkinsonism Juvenile Parkinsonism, Autosomal Dominant Autosomal Recessive Parkinsonism Autosomal Recessive Parkinsonism Parkinsonism, Autosomal Recessive Recessive Parkinsonism, Autosomal

Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".

Diseases [C]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Basal Ganglia Diseases [C10.228.140.079]
Parkinsonian Disorders [C10.228.140.079.862]
Movement Disorders [C10.228.662]
Parkinsonian Disorders [C10.228.662.600]

Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.

Bar chart showing 23 publications over 15 distinct years, with a maximum of 3 publications in 2008 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	0	1
2004	1	0	1
2006	2	0	2
2007	1	0	1
2008	2	1	3
2009	1	0	1
2011	1	0	1
2012	2	0	2
2013	1	0	1
2014	1	0	1
2015	2	0	2
2016	3	0	3
2017	1	0	1
2020	2	0	2

Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.

Farrand AQ, Verner RS, McGuire RM, Helke KL, Hinson VK, Boger HA. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease. Brain Stimul. 2020 Sep - Oct; 13(5):1323-1332.

View in: PubMed
Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D, Chandran R, Shields DC, Farrand AQ, Boger HA, Banik NL. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Exp Neurol. 2020 08; 330:113315.

View in: PubMed
Farrand AQ, Helke KL, Gregory RA, Gooz M, Hinson VK, Boger HA. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease. Brain Stimul. 2017 Nov - Dec; 10(6):1045-1054.

View in: PubMed
Galimberti D, Cioffi SM, Fenoglio C, Serpente M, Oblak AL, Rodriguez-Porcel F, Oldoni E, Hagen MC, Arcaro M, Scarpini E, Ghetti B, Espay AJ. Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation. Mov Disord. 2017 03; 32(3):476-478.

View in: PubMed
Farrand AQ, Gregory RA, Bäckman CM, Helke KL, Boger HA. Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease. Brain Res. 2016 11 15; 1651:88-94.

View in: PubMed
Ahuja M, Ammal Kaidery N, Yang L, Calingasan N, Smirnova N, Gaisin A, Gaisina IN, Gazaryan I, Hushpulian DM, Kaddour-Djebbar I, Bollag WB, Morgan JC, Ratan RR, Starkov AA, Beal MF, Thomas B. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. J Neurosci. 2016 06 08; 36(23):6332-51.

View in: PubMed
Kohl Z, Ben Abdallah N, Vogelgsang J, Tischer L, Deusser J, Amato D, Anderson S, Müller CP, Riess O, Masliah E, Nuber S, Winkler J. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC a-synuclein transgenic rat model of Parkinson's disease. Neurobiol Dis. 2016 Jan; 85:206-217.

View in: PubMed
Samantaray S, Knaryan VH, Shields DC, Cox AA, Haque A, Banik NL. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Mol Neurobiol. 2015 Oct; 52(2):1054-66.

View in: PubMed
Revuelta GJ, Montilla J, Benatar M, Freeman A, Wichmann T, Jinnah HA, Delong MR, Factor SA. An ¹8F-FDG PET study of cervical muscle in parkinsonian anterocollis. J Neurol Sci. 2014 May 15; 340(1-2):174-7.

View in: PubMed
Karakostas T, Hsiang S, Boger H, Middaugh L, Granholm AC. Three-dimensional rodent motion analysis and neurodegenerative disorders. J Neurosci Methods. 2014 Jul 15; 231:31-7.

View in: PubMed

People

Explore

Similar Concepts

Top Journals